Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association

Seminars in Cell and Developmental Biology

Volumn 86, Issue , 2019, Pages 24-35

  Alculumbre, Solana ^a   Raieli, Salvatore ^a   Hoffmann, Caroline ^a   Chelbi, Rabie ^a   Danlos, François Xavier ^a   Soumelis, Vassili ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

Adaptive immunity; Human diseases; Innate sensing; Plasmacytoid dendritic cells; Type I Interferon

Indexed keywords

INTERFERON;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; DISEASE ASSOCIATION; DISEASE CLEARANCE; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASM; PATHOGENICITY; PATHOPHYSIOLOGY; PLASMACYTOID DENDRITIC CELL; REVIEW; DENDRITIC CELL; HYPERSENSITIVITY; IMMUNOLOGY;

AUTOIMMUNE DISEASES; DENDRITIC CELLS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY;

EID: 85042161405     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2018.02.014     Document Type: Review

References (150)

1. Lennert, K., Remmele, W., Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes. Acta Haematol. 19 (1958), 99–113.
2. Liu, Y.-J., Uncover the mystery of plasmacytoid dendritic cell precursors or type 1 interferon producing cells by serendipity. Hum. Immunol. 63 (2002), 1067–1071, 10.1016/S0198-8859(02)00744-9.
3. Siegal, F.P., The nature of the principal type 1 interferon-producing cells in human blood. Science 284:80 (1999), 1835–1837, 10.1126/science.284.5421.1835.
4. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med.(5), 1999, 919–923, 10.1038/11360.
5. Grouard, G., Rissoan, M.C., Filgueira, L., Durand, I., Banchereau, J., Liu, Y.J., The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185 (1997), 1101–1111.
6. Rissoan, M.C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R., Liu, Y.J., Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283 (1999), 1183–1186, 10.1126/science.283.5405.1183.
7. Cella, M., Facchetti, F., Lanzavecchia, A., Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1 (2000), 305–310, 10.1038/79747.
8. Ito, T., Kanzler, H., Duramad, O., Cao, W., Liu, Y., Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107 (2006), 2423–2431, 10.1182/blood-2005-07-2709.
9. Swiecki, M., Colonna, M., The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol., 2015, 10.1038/nri3865.
10. Reizis, B., Bunin, A., Ghosh, H.S., Lewis, K.L., Sisirak, V., Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29 (2011), 163–183, 10.1146/annurev-immunol-031210-101345.
11. Soumelis, V., Liu, Y.-J., From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur. J. Immunol. 36 (2006), 2286–2292, 10.1002/eji.200636026.
12. Clavio, M., Quintino, S., Venturino, C., Ballerini, F., Varaldo, R., Gatto, S., Galbusera, V., Garrone, A., Grasso, R., Canepa, L., Miglino, M., Pierri, I., Gobbi, M., Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?. J. Exp. Clin. Cancer Res. 20 (2001), 351–358.
13. Shao, Y., Kao, C., Tang, S., Cha, T., Tsao, C., Meng, E., Yu, D., Sun, G., Wu, S., Unusual presentation of direct intraperitoneal metastases complicated with massive ascites from plasmacytoid variant of bladder cancer and adenocarcinoma of colon: a case report and literature review. Med. (Baltim.), 96, 2017, e5816, 10.1097/MD.0000000000005816.
14. Liu, Y.-J., IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23 (2005), 275–306, 10.1146/annurev.immunol.23.021704.115633.
15. Ghirelli, C., Zollinger, R., Soumelis, V., Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells. Blood. 115 (2010), 5037–5040, 10.1182/blood-2010-01-266932.
16. Shortman, K., Naik, S.H., Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7 (2007), 19–30, 10.1038/nri1996.
17. Villani, A.-C., Satija, R., Reynolds, G., Sarkizova, S., Shekhar, K., Fletcher, J., Griesbeck, M., Butler, A., Zheng, S., Lazo, S., Jardine, L., Dixon, D., Stephenson, E., Nilsson, E., Grundberg, I., McDonald, D., Filby, A., Li, W., De Jager, P.L., Rozenblatt-Rosen, O., Lane, A.A., Haniffa, M., Regev, A., Hacohen, N., Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science, 356(80), 2017, 10.1126/science.aah4573 eaah4573.
18. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D.W., Schmitz, J., BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol.(165), 2000, 6037–6046, 10.4049/jimmunol.165.11.6037.
19. See, P., Dutertre, C.-A., Chen, J., Günther, P., McGovern, N., Irac, S.E., Gunawan, M., Beyer, M., Händler, K., Duan, K., Bin Sumatoh, H.R., Ruffin, N., Jouve, M., Gea-Mallorquí E., Hennekam, R.C.M., Lim, T., Yip, C.C., Wen, M., Malleret, B., Low, I., Shadan, N.B., Fen, C.F.S., Tay, A., Lum, J., Zolezzi, F., Larbi, A., Poidinger, M., Chan, J.K.Y., Chen, Q., Renia, L., Haniffa, M., Benaroch, P., Schlitzer, A., Schultze, J.L., Newell, E.W., Ginhoux, F., Mapping the human DC lineage through the integration of high-dimensional techniques. Science(80), 2017, 3009, 10.1126/science.eaag3009.
20. Chaudhary, B., Khaled, Y.S., Ammori, B.J., Elkord, E., Neuropilin 1: function and therapeutic potential in cancer. Cancer Immunol. Immunother. 63 (2014), 81–99, 10.1007/s00262-013-1500-0.
21. Tordjman, R., Lepelletier, Y., Lemarchandel, V., Cambot, M., Gaulard, P., Hermine, O., Roméo, P.-H., A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol., 3, 2002, 10.1038/ni789.
22. Alcántara-Hernández, M., Leylek, R., Wagar, L.E., Engleman, E.G., Keler, T., Marinkovich, M.P., Davis, M.M., Nolan, G.P., Idoyaga, J., High-dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization. Immunity, 2017, 1037–1050, 10.1016/j.immuni.2017.11.001.
23. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R.W., Kastelein, R.A., Bazan, F., Liu, Y.J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194 (2001), 863–869, 10.1084/jem.194.6.863.
24. Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., Lanzavecchia, A., Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31 (2001), 3388–3393, 10.1002/1521-4141(200111)31:11&3388:AID-IMMU3388&3.0.CO;2-Q.
25. Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., Reis e Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004), 1529–1531, 10.1126/science.1093616.
26. Lund, J.M., Alexopoulou, L., Sato, A., Karow, M., Adams, N.C., Gale, N.W., Iwasaki, A., Flavell, R.A., Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 5598–5603, 10.1073/pnas.0400937101.
27. Bave, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G.V., Ronnblom, L., Fc RIIa is expressed on natural IFN- -producing cells (plasmacytoid dendritic cells) and is required for the IFN- production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171 (2003), 3296–3302, 10.4049/jimmunol.171.6.3296.
28. Gilliet, M., Cao, W., Liu, Y.-J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8 (2008), 594–606, 10.1038/nri2358.
29. Vasquez, K., Sigrist, K., Kucherlapati, R., Demant, P., Dietrich, W.F., Agoulnik, S., Plus, S., IRF-7 is the master regulator of. Nature 434 (2005), 772–777, 10.1038/nature03419.1.
30. Kim, T., Pazhoor, S., Bao, M., Zhang, Z., Hanabuchi, S., Facchinetti, V., Bover, L., Plumas, J., Chaperot, L., Qin, J., Liu, Y.-J., Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase. A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 15181–15186, 10.1073/pnas.1006539107.
31. Szabo, A., Magyarics, Z., Pazmandi, K., Gopcsa, L., Rajnavolgyi, E., Bacsi, A., TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner. Immunol. Cell Biol. 92 (2014), 671–678, 10.1038/icb.2014.38.
32. Bruni, D., Chazal, M., Sinigaglia, L., Chauveau, L., Schwartz, O., Despres, P., Jouvenet, N., Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons. Sci. Signal., 8, 2015, 10.1126/scisignal.aaa1552 ra25-ra25.
33. Ishikawa, H., Ma, Z., Barber, G.N., STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461 (2009), 788–792, 10.1038/nature08476.
34. Bode, C., Fox, M., Tewary, P., Steinhagen, A., Ellerkmann, R.K., Klinman, D., Baumgarten, G., Hornung, V., Steinhagen, F., Human plasmacytoid dentritic cells elicit a Type I interferon response by sensing DNA via the cGAS-STING signaling pathway. Eur. J. Immunol. 46 (2016), 1615–1621, 10.1002/eji.201546113.
35. Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N., Iwasaki, A., Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315 (2007), 1398–1401, 10.1126/science.1136880.
36. Henault, J., Martinez, J., Riggs, J.M., Tian, J., Mehta, P., Clarke, L., Sasai, M., Latz, E., Brinkmann, M.M., Iwasaki, A., Coyle, A.J., Kolbeck, R., Green, D.R., Sanjuan, M.A., Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37 (2012), 986–997, 10.1016/j.immuni.2012.09.014.
37. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., Bassett, R., Amuro, H., Fukuhara, S., Ito, T., Liu, Y.-J., Gilliet, M., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med., 3, 2011, 10.1126/scitranslmed.3001180 73ra19-73ra19.
38. Kadowaki, N., Antonenko, S., Lau, J.Y., Liu, Y.J., Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192 (2000), 219–226, 10.1084/jem.192.2.219.
39. Asselin-Paturel, C., Brizard, G., Chemin, K., Boonstra, A., O'Garra, A., Vicari, A., Trinchieri, G., Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201 (2005), 1157–1167, 10.1084/jem.20041930.
40. Duramad, O., Fearon, K.L., Chan, J.H., Kanzler, H., Marshall, J.D., Coffman, R.L., Barrat, F.J., IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 102 (2003), 4487–4492, 10.1182/blood-2003-07-2465.
41. Li, L., Liu, S., Zhang, T., Pan, W., Yang, X., Cao, X., Splenic stromal microenvironment negatively regulates virus-activated plasmacytoid dendritic cells through TGF-β. J. Immunol. 180 (2008), 2951–2956, 10.4049/jimmunol.180.5.2951.
42. Naranjo-Gómez, M., Oliva, H., Climent, N., Fernández, M.A., Ruiz-Riol, M., Bofill, M., Gatell, J.M., Gallart, T., Pujol-Borrell, R., Borràs, F.E., Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. Eur. J. Immunol. 37 (2007), 1764–1772, 10.1002/eji.200636980.
43. Kaser, A., Kaser, S., Kaneider, N.C., Enrich, B., Tilg, C.J.H., Interleukin-18 attracts plasmacytoid dendritic cells (DC2) and promotes Th1 induction by DC2 through IL - 18 receptor expression. Hematology. 103 (2003), 648–656, 10.1182/blood-2002-07-2322.
44. Cao, W., Rosen, D.B., Ito, T., Bover, L., Bao, M., Watanabe, G., Yao, Z., Zhang, L., Lanier, L.L., Liu, Y.-J., Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits toll-like receptor-induced interferon production. J. Exp. Med. 203 (2006), 1399–1405, 10.1084/jem.20052454.
45. Cao, W., Bover, L., Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol. Rev. 234 (2010), 163–176, 10.1111/j.0105-2896.2009.00867.x.
46. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., Schmitz, J., BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194 (2001), 1823–1834, 10.1084/jem.194.12.1823.
47. Schroeder, J.T., Bieneman, A.P., Xiao, H., Chichester, K.L., Vasagar, K., Saini, S., Liu, M.C., TLR- and FceRi-mediated responses opposed one another in plasmacytoid dendritic cells by down-regulating receptor expression. J. Immunol. 175 (2005), 5724–5731, 10.4049/jimmunol.175.9.5724.
48. Fuchs, A., Cella, M., Kondo, T., Colonna, M., Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 106 (2005), 2076–2082, 10.1182/blood-2004-12-4802.
49. Ju, X., Zenke, M., Hart, D.N.J., Clark, G.J., CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 112 (2008), 1184–1194, 10.1182/blood-2007-12-127951.
50. Meyer-Wentrup, F., Benitez-Ribas, D., Tacken, P.J., Punt, C.J.A., Figdor, C.G., de Vries, I.J.M., Adema, G.J., Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111 (2008), 4245–4253, 10.1182/blood-2007-03-081398.
51. Coccia, E.M., Severa, M., Giacomini, E., Monneron, D., Remoli, M.E., Julkunen, I., Cella, M., Lande, R., Uzé G., Viral infection and toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34 (2004), 796–805, 10.1002/eji.200324610.
52. Schneider, W.M., Chevillotte, M.D., Rice, C.M., Interferon-stimulated genes: a complex web of host defenses. Annu. Rev. Immunol. 32 (2014), 513–545, 10.1146/annurev-immunol-032713-120231.
53. Luft, T., Pang, K.C., Thomas, E., Hertzog, P., Hart, D.N., Trapani, J., Cebon, J., Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161 (1998), 1947–1953.
54. Santini, S.M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., Belardelli, F., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 51200 (2000), 1777–1788, 10.1084/jem.191.10.1777.
55. Mathan, T.S.M.M., Figdor, C.G., Buschow, S.I., Human plasmacytoid dendritic cells: from molecules to intercellular communication network. Front. Immunol., 4, 2013, 372, 10.3389/fimmu.2013.00372.
56. Jego, G., Palucka, A.K., Blanck, J.-P.J., Chalouni, C., Pascual, V., Banchereau, J., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003), 225–234 doi:S1074761303002085 [pii].
57. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., Tough, D.F., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4 (2003), 1009–1015, 10.1038/ni978.
58. Fitzgerald-Bocarsly, P., Feng, D., The role of type I interferon production by dendritic cells in host defense. Biochimie. 89 (2009), 843–855, 10.1016/j.biochi.2007.04.018.
59. Moseman, E.A., Liang, X., Dawson, A.J., Panoskaltsis-Mortari, A., Krieg, A.M., Liu, Y.-J., Blazar, B.R., Chen, W., Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. 173 (2004), 4433–4442.
60. Ito, T., Yang, M., Wang, Y.-H., Lande, R., Gregorio, J., Perng, O.A., Qin, X.-F., Liu, Y.-J., Gilliet, M., Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204 (2007), 105–115, 10.1084/jem.20061660.
61. Hanabuchi, S., Ito, T., Park, W.-R., Watanabe, N., Shaw, J.L., Roman, E., Arima, K., Wang, Y.-H., Voo, K.S., Cao, W., Liu, Y.-J., Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3++ Regulatory T cells in Human Thymus. J. Immunol. 184 (2010), 2999–3007, 10.4049/jimmunol.0804106.
62. Alculumbre, S.G., Saint-André V., Di Domizio, J., Vargas, P., Sirven, P., Bost, P., Maurin, M., Maiuri, P., Wery, M., Roman, M.S., Savey, L., Touzot, M., Terrier, B., Saadoun, D., Conrad, C., Gilliet, M., Morillon, A., Soumelis, V., Diversification of human plasmacytoid predendritic cells in response to a single stimulus. Nat. Immunol., 19, 2017, 10.1038/s41590-017-0012-z.
63. Villadangos, J.A., Young, L., Antigen-Presentation Properties of plasmacytoid dendritic cells. Immunity 29 (2008), 352–361, 10.1016/j.immuni.2008.09.002.
64. Hoeffel, G., Ripoche, A.C., Matheoud, D., Nascimbeni, M., Escriou, N., Lebon, P., Heshmati, F., Guillet, J.G., Gannagé M., Caillat-Zucman, S., Casartelli, N., Schwartz, O., De la Salle, H., Hanau, D., Hosmalin, A., Marañón, C., Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27 (2007), 481–492, 10.1016/j.immuni.2007.07.021.
65. Di Pucchio, T., Chatterjee, B., Smed-Sörensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., Connolly, J.E., Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9 (2008), 551–557, 10.1038/ni.1602.
66. Segura, E., Durand, M., Amigorena, S., Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. J. Exp. Med. 210 (2013), 1035–1047, 10.1084/jem.20121103.
67. Reizis, B., Colonna, M., Trinchieri, G., Barrat, F., Gilliet, M., Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?. Nat. Rev. Immunol. 11 (2011), 558–565, 10.1038/nri3027.
68. Galibert, L., Maliszewski, C.R., Vandenabeele, S., Plasmacytoid monocytes/T cells: a dendritic cell lineage?. Semin. Immunol. 13 (2001), 283–289, 10.1006/smim.2001.0324.
69. Swiecki, M., Wang, Y., Gilfillan, S., Colonna, M., Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 9 (2013), 2–11, 10.1371/journal.ppat.1003728.
70. Wang, Y., Swiecki, M., McCartney, S.A., Colonna, M., dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol. Rev. 243 (2011), 74–90, 10.1111/j.1600-065X.2011.01049.x.
71. Ciancanelli, M.J., Huang, S.X.L., Luthra, P., Garner, H., Itan, Y., Volpi, S., Lafaille, F.G., Trouillet, C., Schmolke, M., Albrecht, R.A., Israelsson, E., Lim, H.K., Casadio, M., Hermesh, T., Lorenzo, L., Leung, L.W., Pedergnana, V., Boisson, B., Okada, S., Picard, C., Ringuier, B., Troussier, F., Chaussabel, D., Abel, L., Pellier, I., Notarangelo, L.D., Garcia-Sastre, A., Basler, C.F., Geissmann, F., Zhang, S.-Y., Snoeck, H.-W., Casanova, J.-L., Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348:80 (2015), 448–453, 10.1126/science.aaa1578.
72. Davidson, S., Crotta, S., McCabe, T.M., Wack, A., Pathogenic potential of interferon αβ in acute influenza infection. Nat. Commun., 5, 2014, 10.1038/ncomms4864.
73. Li, Q., Estes, J.D., Schlievert, P.M., Duan, L., Brosnahan, A.J., Southern, P.J., Reilly, C.S., Peterson, M.L., Schultz-Darken, N., Brunner, K.G., Nephew, K.R., Pambuccian, S., Lifson, J.D., Carlis, J.V., Haase, A.T., Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 (2009), 1034–1038, 10.1038/nature07831.
74. O'Brien, M., Manches, O., Sabado, R.L., Baranda, S.J., Wang, Y., Marie, I., Rolnitzky, L., Markowitz, M., Margolis, D.M., Levy, D., Bhardwaj, N., Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype. J. Clin. Invest. 121 (2011), 1088–1101, 10.1172/JCI44960.
75. Manches, O., Fernandez, M.V., Plumas, J., Chaperot, L., Bhardwaj, N., Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 14122–14127, 10.1073/pnas.1204032109.
76. Li, H., Goepfert, P., Reeves, R.K., Plasmacytoid Dendritic Cells from HIV-1 elite controllers maintain a gut-homing phenotype associated with immune activation. AIDS Res. Hum. Retroviruses. 30 (2014), 1–3, 10.1089/aid.2014.0174.
77. Sandler, N.G., Bosinger, S.E., Estes, J.D., Zhu, R.T.R., Tharp, G.K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K.N., del Prete, G.Q., Hill, B.J., Timmer, J.K., Reiss, E., Yarden, G., Darko, S., Contijoch, E., Todd, J.P., Silvestri, G., Nason, M., Norgren, R.B., Keele, B.F., Rao, S., Langer, J.A., Lifson, J.D., Schreiber, G., Douek, D.C., Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511 (2014), 601–605, 10.1038/nature13554.
78. Duan, X.Z., Wang, M., Li, H.W., Zhuang, H., Xu, D., Wang, F.S., Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J. Clin. Immunol. 24 (2004), 637–646, 10.1007/s10875-004-6249-y.
79. Woltman, A.M., Op den Brouw, M.L., Biesta, P.J., Shi, C.C., Janssen, H.L.A., Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS One, 6, 2011, e15324, 10.1371/journal.pone.0015324.
80. Yonkers, N.L., Rodriguez, B., Milkovich, K.A., Asaad, R., Lederman, M.M., Heeger, P.S., Anthony, D.D., TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection. J. Immunol. 178 (2007), 4436–4444, 10.4049/jimmunol.178.7.4436.
81. Zhang, S., Kodys, K., Babcock, G.J., Szabo, G., CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha. Hepatology. 58 (2013), 940–949, 10.1002/hep.25827.
82. Lenz, P., Lowy, D., Schiller, J., Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells. Eur. J. Immunol. 35 (2005), 1548–1556, 10.1002/eji.200425547.
83. Lozza, L., Farinacci, M., Bechtle, M., Stäber, M., Zedler, U., Baiocchini, A., Del Nonno, F., Kaufmann, S.H.E., Communication between human dendritic cell subsets in tuberculosis: requirements for naive CD4(+) T cell stimulation. Front. Immunol., 5, 2014, 324, 10.3389/fimmu.2014.00324.
84. Teles, R.M.B., Graeber, T.G., Krutzik, S.R., Montoya, D., Schenk, M., Lee, D.J., Komisopoulou, E., Kelly-Scumpia, K., Chun, R., Iyer, S.S., Sarno, E.N., Rea, T.H., Hewison, M., Adams, J.S., Popper, S.J., Relman, D.A., Stenger, S., Bloom, B.R., Cheng, G., Modlin, R.L., Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339 (2013), 1448–1453, 10.1126/science.1233665.
85. Michea, P., Vargas, P., Donnadieu, M.-H., Rosemblatt, M., Bono, M.R., Duménil, G., Soumelis, V., Epithelial control of the human pDC response to extracellular bacteria. Eur. J. Immunol. 43 (2013), 1264–1273, 10.1002/eji.201242990.
86. Parcina, M., Miranda-Garcia, M.A., Durlanik, S., Ziegler, S., Over, B., Georg, P., Foermer, S., Ammann, S., Hilmi, D., Weber, K.-J., Schiller, M., Heeg, K., Schneider-Brachert, W., Götz, F., Bekeredjian-Ding, I., Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus. J. Immunol. 190 (2013), 1591–1602, 10.4049/jimmunol.1201222.
87. Ramirez-Ortiz, Z.G., Specht, C.A., Wang, J.P., Lee, C.K., Bartholomeu, D.C., Gazzinelli, R.T., Levitz, S.M., Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect. Immun. 76 (2008), 2123–2129, 10.1128/IAI.00047-08.
88. Ramirez-Ortiz, Z.G., Lee, C.K., Wang, J.P., Boon, L., Specht, C.A., Levitz, S.M., A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe. 9 (2011), 415–424, 10.1016/j.chom.2011.04.007.
89. Loures, F.V., Röhm, M., Lee, C.K., Santos, E., Wang, J.P., Specht, C.A., Calich, V.L.G., Urban, C.F., Levitz, S.M., Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog., 11, 2015, e1004643, 10.1371/journal.ppat.1004643.
90. Loughland, J.R., Minigo, G., Sarovich, D.S., Field, M., Tipping, P.E., Montes de Oca, M., Piera, K.A., Amante, F.H., Barber, B.E., Grigg, M.J., William, T., Good, M.F., Doolan, D.L., Engwerda, C.R., Anstey, N.M., McCarthy, J.S., Woodberry, T., Plasmacytoid dendritic cells appear inactive during sub-microscopic Plasmodium falciparum blood-stage infection, yet retain their ability to respond to TLR stimulation. Sci. Rep., 7, 2017, 2596, 10.1038/s41598-017-02096-2.
91. Yu, X., Cai, B., Wang, M., Tan, P., Ding, X., Wu, J., Li, J., Li, Q., Liu, P., Xing, C., Wang, H.Y., Su, X., Wang, R.-F., Cross-regulation of two Type I interferon signaling pathways in plasmacytoid dendritic cells controls anti-malaria immunity and host mortality. Immunity 45 (2016), 1093–1107, 10.1016/j.immuni.2016.10.001.
92. Bengtsson, A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., Rönnblom, L., Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9 (2000), 664–671, 10.1191/096120300674499064.
93. Rönnblom, L., Alm, G.V., A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194 (2001), F59–F63, 10.1084/jem.194.12.f59.
94. Means, T.K., Latz, E., Hayashi, F., Murali, M.R., Golenbock, D.T., Luster, A.D., Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115 (2005), 407–417, 10.1172/JCI200523025.
95. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F.J., Zal, T., Gilliet, M., Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206 (2009), 1983–1994, 10.1084/jem.20090480.
96. Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P., Jahnsen, F.L., Plasmacytoid dendritic cells (natural interferon- α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159 (2001), 237–243, 10.1016/S0002-9440(10)61689-6.
97. Fiore, N., Castellano, G., Blasi, A., Capobianco, C., Loverre, A., Montinaro, V., Netti, S., Torres, D., Manno, C., Grandaliano, G., Ranieri, E., Schena, F.P., Gesualdo, L., Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45 (2008), 259–265, 10.1016/j.molimm.2007.04.029.
98. Albanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.-D., Parmentier, M., De Pità O., Girolomoni, G., Sozzani, S., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med., 206, 2009, 10.1084/jem.20080129.
99. Hagberg, N., Berggren, O., Leonard, D., Weber, G., Bryceson, Y.T., Alm, G.V., Eloranta, M.-L., Rönnblom, L., IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1. J. Immunol. 186 (2011), 5085–5094, 10.4049/jimmunol.1003349.
100. Menon, M., Blair, P., Isenberg, D., Mauri, C., A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44 (2016), 683–697, 10.1016/j.immuni.2016.02.012.
101. Harley, I.T.W., Kaufman, K.M., Langefeld, C.D., Harley, J.B., Kelly, J.A., Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat. Rev. Genet. 10 (2009), 285–290, 10.1038/nrg2571.
102. Berggren, O., Alexsson, A., Morris, D.L., Tandre, K., Weber, G., Vyse, T.J., Syvänen, A.-C., Rönnblom, L., Eloranta, M.-L., IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases. Hum. Mol. Genet. 24 (2015), 3571–3581, 10.1093/hmg/ddv095.
103. Fu, Q., Zhao, J., Qian, X., Wong, J.L.H., Kaufman, K.M., Yu, C.Y., Mok, M.Y., Harley, J.B., Guthridge, J.M., Song, Y.W., Cho, S.-K., Bae, S.-C., Grossman, J.M., Hahn, B.H., Arnett, F.C., Shen, N., Tsao, B.P., Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum. 63 (2011), 749–754, 10.1002/art.30193.
104. Rossato, M., Affandi, A.J., Thordardottir, S., Wichers, C.G.K., Cossu, M., Broen, J.C.A., Moret, F.M., Bossini-Castillo, L., Chouri, E., van Bon, L., Wolters, F., Marut, W., van der Kroef, M., Silva-Cardoso, S., Bekker, C.P.J., Dolstra, H., van Laar, J.M., Martin, J., van Roon, J.A.G., Reedquist, K.A., Beretta, L., Radstake, T.R.D.J., Expression of miR-618 in plasmacytoid dendritic cells from systemic sclerosis patients is associated with their altered frequency and activation. Arthritis Rheumatol., 72, 2017, 596, 10.1002/art.40163 LP-601.
105. Higgs, B.W., Liu, Z., White, B., Zhu, W., White, W.I., Morehouse, C., Brohawn, P., Kiener, P.A., Richman, L., Fiorentino, D., Greenberg, S.A., Jallal, B., Yao, Y., Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann. Rheum. Dis., 70, 2011, 2029 LP-2036.
106. Shrestha, S., Wershil, B., Sarwark, J.F., Niewold, T.B., Philipp, T., Pachman, L.M., Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum. 62 (2010), 2813–2822, 10.1002/art.27529.
107. Eloranta, M.-L., Barbasso Helmers, S., Ulfgren, A.-K., R?nnblom, L., Alm, G.V., Lundberg, I.E., A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum. 56 (2007), 3112–3124, 10.1002/art.22860.
108. Kim, D., Peck, A., Santer, D., Patole, P., Schwartz, S.M., Molitor, J.A., Arnett, F.C., Elkon, K.B., Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-α activity with lung fibrosis. Arthritis Rheum. 58 (2008), 2163–2173, 10.1002/art.23486.
109. Rossato, M., Affandi, A.J., Thordardottir, S., Wichers, C.G.K., Cossu, M., Broen, J.C.A., Moret, F.M., Bossini-Castillo, L., Chouri, E., van Bon, L., Wolters, F., Marut, W., van der Kroef, M., Silva-Cardoso, S., Bekker, C.P.J., Dolstra, H., van Laar, J.M., Martin, J., van Roon, J.A.G., Reedquist, K.A., Beretta, L., Radstake, T.R.D.J., Expression of miR-618 in plasmacytoid dendritic cells from systemic sclerosis patients is associated with their altered frequency and activation. Arthritis Rheumatol. (Hoboken, N.J.). 11 (2017), 300–308, 10.1002/art.40163.
110. Sacre, K., Criswell, L.A., Mccune, J.M., Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res. Ther., 14(3), 2012, 10.1186/ar3895.
111. Costedoat-Chalumeau, N., Amoura, Z., Hulot, J.-S., Aymard, G., Leroux, G., Marra, D., Lechat, P., Piette, J.-C., Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus. Ann. Rheum. Dis. 66 (2007), 821–824, 10.1136/ard.2006.067835.
112. Schwartz, D.M., Bonelli, M., Gadina, M., O'Shea, J.J., Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat. Rev. Rheumatol. 12 (2015), 25–36, 10.1038/nrrheum.2015.167.
113. Furie, R., Khamashta, M., Merrill, J.T., Werth, V.P., Kalunian, K., Brohawn, P., Illei, G.G., Drappa, J., Wang, L., Yoo, S., Anifrolumab, an anti–interferon-α receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheumatol. 69 (2017), 376–386, 10.1002/art.39962.
114. Jahnsen, F.L., Lund-Johansen, F., Dunne, J.F., Farkas, L., Haye, R., Brandtzaeg, P., Experimentally induced recruitment of plasmacytoid (CD123high) Dendritic Cells in Human Nasal Allergy. J. Immunol. 165 (2000), 4062–4068, 10.4049/jimmunol.165.7.4062.
115. Dua, B., Watson, R.M., Gauvreau, G.M., O'Byrne, P.M., de Saint-Vis, B., Franz-Bacon, K., et al. Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J. Allergy Clin. Immunol. 126 (2010), 133–139, 10.1016/j.jaci.2010.04.006.
116. Upham, J.W., Zhang, G., Rate, A., Yerkovich, S.T., Kusel, M., Sly, P.D., Holt, P.G., Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory tract infections and wheezing. J. Allergy Clin. Immunol. 124 (2009), 707–713, 10.1016/j.jaci.2009.07.009 e2.
117. Bratke, K., Prieschenk, C., Garbe, K., Kuepper, M., Lommatzsch, M., Virchow, J.C., Plasmacytoid dendritic cells in allergic asthma and the role of inhaled corticosteroid treatment. Clin. Exp. Allergy. 43 (2013), 312–321, 10.1111/cea.12064.
118. Tversky, J.R., Le, T.V., Bieneman, A.P., Chichester, K.L., Hamilton, R.G., Schroeder, J.T., Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-? via toll-like receptor 9. Clin. Exp. Allergy. 38 (2008), 781–788, 10.1111/j.1365-2222.2008.02954.x.
119. Pritchard, A.L., Carroll, M.L., Burel, J.G., White, O.J., Phipps, S., Upham, J.W., Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: A regulatory mechanism with relevance to asthma. J. Immunol. 188 (2012), 5898–5905, 10.4049/jimmunol.1103507.
120. Froidure, A., Vandenplas, O., D'Alpaos, V., Evrard, G., Pilette, C., Defects in plasmacytoid dendritic cell expression of inducible costimulator ligand and IFN-α are associated in asthma with disease persistence. Am. J. Respir. Crit. Care Med. 192 (2015), 392–395, 10.1164/rccm.201503-0479LE.
121. de Heer, H.J., Hammad, H., Soullié T., Hijdra, D., Vos, N., Willart, M.A.M., Hoogsteden, H.C., Lambrecht, B.N., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200 (2004), 89–98, 10.1084/jem.20040035.
122. Hartmann, E., Wollenberg, B., Rothenfusser, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., Hartmann, G., Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 1 (2003), 6478–6487.
123. Treilleux, I., Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10 (2004), 7466–7474, 10.1158/1078-0432.CCR-04-0684.
124. Labidi-Galy, S.I., Sisirak, V., Meeus, P., Gobert, M., Treilleux, I., Bajard, A., Combes, J.D., Faget, J., Mithieux, F., Cassignol, A., Tredan, O., Durand, I., Ménétrier-Caux, C., Caux, C., Blay, J.Y., Ray-Coquard, I., Bendriss-Vermare, N., Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 71 (2011), 5423–5434, 10.1158/0008-5472.CAN-11-0367.
125. Ray, A., Das, D.S., Song, Y., Macri, V., Richardson, P., Brooks, C.L., Chauhan, D., Anderson, K.C., A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis, and cancer stem-like cells. Nat. Publ. Gr., 2017, 1–9, 10.1038/leu.2017.135.
126. Aspord, C., Leccia, M.-T., Charles, J., Plumas, J., Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL. Cancer Immunol. Res. 1 (2013), 402–415, 10.1158/2326-6066.CIR-13-0114-T.
127. Liu, Y., Zeng, G., Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J. Immunother. 35 (2012), 299–308, 10.1097/CJI.0b013e3182518e83.
128. Ghirelli, C., Reyal, F., Jeanmougin, M., Zollinger, R., Sirven, P., Michea, P., Caux, C., Bendriss-Vermare, N., Donnadieu, M.H., Caly, M., Fourchotte, V., Vincent-Salomon, A., Sigal-Zafrani, B., Sastre-Garau, X., Soumelis, V., Breast cancer cell-derived GM-CSF licenses regulatory Th2 induction by plasmacytoid predendritic cells in aggressive disease subtypes. Cancer Res. 75 (2015), 2775–2787, 10.1158/0008-5472.CAN-14-2386.
129. Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pacheco, Y., Lebecque, S., Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J. Immunol. 178 (2007), 2763–2769, 10.4049/jimmunol.178.5.2763.
130. Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S.I., Goddard-Leon, S., Durand, I., Le Mercier, I., Bajard, A., Bachelot, T., Puisieux, A., Puisieux, I., Blay, J.Y., Ménétrier-Caux, C., Caux, C., Bendriss-Vermare, N., Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 72 (2012), 5188–5197, 10.1158/0008-5472.CAN-11-3468.
131. Chevolet, I., Speeckaert, R., Schreuer, M., Neyns, B., Krysko, O., Bachert, C., Hennart, B., Allorge, D., van Geel, N., Van Gele, M., Brochez, L., Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma. Oncoimmunology., 4, 2015, e982382, 10.4161/2162402X.2014.982382.
132. Yamahira, A., Narita, M., Iwabuchi, M., Uchiyama, T., Iwaya, S., Ohiwa, R., Nishizawa, Y., Suzuki, T., Yokoyama, Y., Hashimoto, S., Takizawa, J., Sone, H., Takahashi, M., Activation of the leukemia plasmacytoid dendritic cell line PMDC05 by Toho-1, a novel IDO inhibitor. Anticancer Res. 34 (2014), 4021–4028.
133. Sisirak, V., Vey, N., Goutagny, N., Renaudineau, S., Malfroy, M., Thys, S., Treilleux, I., Labidi-Galy, S.I., Bachelot, T., Dezutter-Dambuyant, C., Ménétrier-Caux, C., Blay, J.-Y., Caux, C., Bendriss-Vermare, N., Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells. Int. J. Cancer. 133 (2013), 771–778, 10.1002/ijc.28072.
134. Beckebaum, S., Zhang, X., Chen, X., Yu, Z., Frilling, A., Dworacki, G., Grosse-Wilde, H., Broelsch, C.E., Gerken, G., Cicinnati, V.R., Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin. Cancer Res. 10 (2004), 7260–7269, 10.1158/1078-0432.CCR-04-0872.
135. Bekeredjian-Ding, I., Schäfer, M., Hartmann, E., Pries, R., Parcina, M., Schneider, P., Giese, T., Endres, S., Wollenberg, B., Hartmann, G., Tumour-derived prostaglandin E 2 and transforming growth factor-β synergize to inhibit plasmacytoid dendritic cell-derived interferon-α. Immunology 128 (2009), 439–450, 10.1111/j.1365-2567.2009.03134.x.
136. Tel, J., Anguille, S., Waterborg, C.E.J., Smits, E.L., Figdor, C.G., de Vries, I.J.M., Tumoricidal activity of human dendritic cells. Trends Immunol. 35 (2014), 38–46, 10.1016/j.it.2013.10.007.
137. Matsui, T., Connolly, J.E., Michnevitz, M., Chaussabel, D., Yu, C.-I., Glaser, C., Tindle, S., Pypaert, M., Freitas, H., Piqueras, B., Banchereau, J., Palucka, A.K., CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J. Immunol. 182 (2009), 6815–6823, 10.4049/jimmunol.0802008.
138. Matta, B.M., Castellaneta, A., Thomson, A.W., Tolerogenic plasmacytoid DC. Eur. J. Immunol. 40 (2010), 2667–2676, 10.1002/eji.201040839.
139. Kobold, S., Wiedemann, G., Rothenfußer, S., Endres, S., Modes of action of TLR7 agonists in cancer therapy. Immunotherapy 6 (2014), 1085–1095, 10.2217/imt.14.75.
140. Schön, M.P., Wienrich, B.G., Drewniok, C., Bong, A.B., Eberle, J., Geilen, C.C., Gollnick, H., Schön, M., Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J. Invest. Dermatol. 122 (2004), 1266–1276, 10.1111/j.0022-202X.2004.22528.x.
141. Huang, S.-W., Chang, S.-H., Mu, S.-W., Jiang, H.-Y., Wang, S.-T., Kao, J.-K., Huang, J.-L., Wu, C.-Y., Chen, Y.-J., Shieh, J.-J., Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line. J. Dermatol. Sci. 81 (2016), 182–191, 10.1016/j.jdermsci.2015.12.011.
142. Tel, J., Aarntzen, E.H.J.G., Baba, T., Schreibelt, G., Schulte, B.M., Benitez-Ribas, D., Boerman, O.C., Croockewit, S., Oyen, W.J.G., van Rossum, M., Winkels, G., Coulie, P.G., Punt, C.J.A., Figdor, C.G., de Vries, I.J.M., Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res. 73 (2013), 1063–1075, 10.1158/0008-5472.CAN-12-2583.
143. Tel, J., Koornstra, R., de Haas, N., van Deutekom, V., Westdorp, H., Boudewijns, S., van Erp, N., Di Blasio, S., Gerritsen, W., Figdor, C.G., de Vries, I.J.M., Hato, S.V., Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition. J. Transl. Med., 14, 2016, 88, 10.1186/s12967-016-0844-6.
144. Kranz, L.M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K.C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., Grunwitz, C., Vormehr, M., Hüsemann, Y., Selmi, A., Kuhn, A.N., Buck, J., Derhovanessian, E., Rae, R., Attig, S., Diekmann, J., Jabulowsky, R.A., Heesch, S., Hassel, J., Langguth, P., Grabbe, S., Huber, C., Türeci, Ö., Sahin, U., Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534 (2016), 396–401, 10.1038/nature18300.
145. Cappuccio, A., Zollinger, R., Schenk, M., Walczak, A., Servant, N., Barillot, E., Hupé P., Modlin, R.L., Soumelis, V., Combinatorial code governing cellular responses to complex stimuli. Nat. Commun., 6, 2015, 6847, 10.1038/ncomms7847.
146. Kim, H.Y., Kim, H.R., Lee, S.H., Advances in systems biology approaches for autoimmune diseases. Immune Netw. 14 (2014), 73–80, 10.4110/in.2014.14.2.73.
147. Liao, X., Li, S., Settlage, R.E., Sun, S., Ren, J., Reihl, A.M., Zhang, H., Karyala, S.V., Reilly, C.M., Ahmed, S.A., Luo, X.M., Edge, Cutting, Plasmacytoid dendritic cells in late-stage lupus mice defective in producing IFN-α. J. Immunol. 195 (2015), 4578–4582, 10.4049/jimmunol.1501157.
148. Sisirak, V., Ganguly, D., Lewis, K.L., Couillault, C., Tanaka, L., Bolland, S., D'Agati, V., Elkon, K.B., Reizis, B., Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 211 (2014), 1969–1976, 10.1084/jem.20132522.
149. Kim, T.W., Hong, S., Lin, Y., Murat, E., Joo, H., Kim, T., Pascual, V., Liu, Y.-J., Transcriptional repression of IFN regulatory factor 7 by MYC is critical for Type I IFN production in human plasmacytoid dendritic cells. J. Immunol. 197 (2016), 3348–3359, 10.4049/jimmunol.1502385.
150. Worah, K., Mathan, T.S.M., Vu Manh, T.P., Keerthikumar, S., Schreibelt, G., Tel, J., Duiveman-de Boer, T., Sköld, A.E., van Spriel, A.B., de Vries, I.J.M., Huynen, M.A., Wessels, H.J., Gloerich, J., Dalod, M., Lasonder, E., Figdor, C.G., Buschow, S.I., Proteomics of human dendritic cell subsets reveals subset-specific surface markers and differential inflammasome function. Cell Rep. 16 (2016), 2953–2966, 10.1016/j.celrep.2016.08.023.